BOTOX DIN 02531577
Status: Marketed
Holder: ABBVIE CORPORATION
Available to quote
Health Canada record
| Active ingredient(s) | ONABOTULINUMTOXINA 50 UNIT |
|---|
| Dosage form | Powder For Solution |
|---|
| Route | Intramuscular; Intradermal; Intradetrusorial |
|---|
| Schedule | SCHEDULE D; PRESCRIPTION |
|---|
| Class | Human |
|---|
| ATC | M03AX01 BOTULINUM TOXIN |
|---|
| Original market date | 20-Jun-2023 |
|---|
| Current status date | 20-Jun-2023 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
AbbVie Corporation — licence 101988, currently licensed, last inspection rating C (2023-07-18).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ONABOTULINUMTOXINA
| DIN | Product | Company | Form | Strength | Status |
|---|
| 01981501 | BOTOX | ABBVIE CORPORATION | Powder For Solution | ONABOTULINUMTOXINA 100 UNIT | Marketed |
| 02531585 | BOTOX | ABBVIE CORPORATION | Powder For Solution | ONABOTULINUMTOXINA 200 UNIT | Marketed |
| 02243721 | BOTOX COSMETIC | ABBVIE CORPORATION | Powder For Solution | ONABOTULINUMTOXINA 100 UNIT | Marketed |
| 02531445 | BOTOX COSMETIC | ABBVIE CORPORATION | Powder For Solution | ONABOTULINUMTOXINA 50 UNIT | Approved |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 29123 | 2022-10-03 | Supplement to a New Drug Submission (SNDS) | Labelling updates |
Request a quote for BOTOX
How to read a Canadian DIN record